Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T13:44:29.133Z Has data issue: false hasContentIssue false
  • English
  • Français

Pathobiology of Neurosarcoidosis and Clinicopathologic Correlation

Published online by Cambridge University Press:  18 September 2015

Herbert J. Manz
Herbert J. Manz*
Affiliation:
Department of Pathology, Georgetown University, Washington, D.C.
*
Department of Pathology, Georgetown University Medical Center, 3900 Reservoir Road, N.W., Washington, D.C. 20007 U.S.A.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In a retrospective study of 4,294 consecutive postmortem cases, there were 15 with histologically proved sarcoidosis, including 4 with CNS involvement. Whereas in previously reported autopsy series the prevalence of neurosarcoidosis was 15%, it is 27% in this review. Five cases with incidental, clinically inapparent sarcoidosis died at a mean age of 54.6 years; those six with systemic sarcoidosis, not involving the CNS, died at a mean age of 47.0 years; while those four with a variety of neurologic manifestations in addition to systemic sarcoidosis died at a mean age of 38.2 years. Thus, it appears that at one end of the spectrum of morbidity, sarcoidosis may cause no or only trivial symptoms and permit prolonged survival. At the other extreme, sarcoidosis may affect a younger population more severely. CNS involvement occurs relatively early in the course and is rather rapidly progressive, accounting for the poor prognosis, despite appropriate medical and neurosurgical management. In its turn, neurosarcoidosis may present with a variety of signs and symptoms, depending on the site of involvement along the craniospinal axis. This feature is illustrated by the manifestations of compression myelopathy, hydrocephalus with dementia, hydrocephalus with seizures and ataxia, and anosmia, blindness, seizures, and diabetes insipidus. In addition, one patient developed a Nocardia brain abscess as a complication of the altered immune system in sarcoidosis.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 10 , Issue 1 , February 1983 , pp. 50 - 55
Copyright
Copyright © Canadian Neurological Sciences Federation 1983

References

Aszkanazy, C.L. (1952). Sarcoidosis of the central nervous system. J. Neuropath. Exp. Neurol. 11:392–400.CrossRefGoogle ScholarPubMed
Colover, J. (1948). Sarcoidosis with involvement of the nervous system. Brain 71:451–475.CrossRefGoogle ScholarPubMed
Day, A.L. and Sypert, G.W. (1977). Spinal cord sarcoidosis. Ann. Neurol. 1:79–85.CrossRefGoogle ScholarPubMed
Delaney, P. (1977). Neurologic manifestations in sarcoidosis. Review of the literature, with a report of 23 cases. Ann. Intern. Med. 87:336–345.CrossRefGoogle ScholarPubMed
Douglas, A.C. and Maloney, A.F.J. (1973). Sarcoidosis of the central nervous system. J. Neurol. Neurosurg. Psychiat. 36:1024–1033.Google ScholarPubMed
Gilmore, K., Rudden, M., and Kalman, T.P. (1980). Psychiatric manifestations of sarcoidosis. Can. J. Psychiatry 25:329–331.CrossRefGoogle ScholarPubMed
Herring, A.B. and Urich, H. (1969). Sarcoidosis of the central nervous system. J. Neurol. Sci. 9:405–422.CrossRefGoogle ScholarPubMed
James, D.G. and Neville, E. (1977). “Pathobiology of Sarcoidosis.” In: Pathobiology Annual, Vol. 7, Ioachim, H.L., ed., pp. 31–61. Appleton-Century-Crofts, New York.Google Scholar
James, D.G., Turiaf, J., Hosoda, Y., Williams, W.J., Israel, H.L., Douglas, A.C., and Siltzbach, L.E. (1976). Description of sarcoidosis: report of the subcommittee on classification and definition. Ann. N.Y. Acad. Sci. 278:742.Google ScholarPubMed
Kumpe, D.A., Rao, C.V.G.K., Garcia, J.H., and Heck, A.F. (1979). Intracranial neurosarcoidosis. J. Comput. Assist. Tomogr. 3:324–330.CrossRefGoogle ScholarPubMed
Mathews, T., Wisotzky, H., and Moossy, J. (1976). Multiple central nervous system infections in progressive multifocal leukoencephalopathy. Neurology 26:9–14.CrossRefGoogle ScholarPubMed
Ricker, W. and Clark, M. (1949). Sarcoidosis. A clinicopathologic review of three hundred cases, including twenty-two autopsies. Am. J. Clin. Pathol. 19:725–749.Google Scholar
Slade, W.R. (1979). Sarcoid of the nervous system. J. Nat. Med. Assoc. 71:1205–1208.Google ScholarPubMed
Stuart, C.A., Neelon, F.A., and Lebovitz, H.E. (1978). Hypothalamic insufficiency: The cause of hypopituitarism in sarcoidosis. Ann. Intern. Med. 88:589–594.CrossRefGoogle ScholarPubMed
Urich, H. (1976): The optic pathway in neurosarcoidosis. Ann. N.Y. Acad. Sci. 278:406–415.CrossRefGoogle ScholarPubMed
Waxman, J.S. and Sher, J.H. (1979). The spectrum of central nervous system sarcoidosis. A clinical and pathologic study. Mt. Sinai J. Med. 46:309–317.Google ScholarPubMed